Efeito do probiótico Bifidobacterium animalis subs. Lactis HN019 como coadjuvante no tratamento periodontal em pacientes diabéticos tipo II.

Abstract

The objective of this study was to evaluate the action of the probiotic Bifidobacterium animalis subs. lactis HN019 as an adjunct in the treatment of PD in type II diabetic patients. The sample of 17 participants was divided into a test group (n=6), which received scaling and root planing therapy (SRP) and probiotic fermented milk, and the control group (n=11), which received SRP and placebo sterilized milk. The volunteers ingested the probiotic milk and the placebo once a day for 90 days. The following parameters were evaluated: bleeding on probing (BoP), probing depth (PD), gingival recession (GR), clinical attachment level (CAL), glycated hemoglobin (HbA1c), fasting glucose, total cholesterol, HDL, LDL, triglycerides, body mass index (BMI) and waist-to-hip ratio (WHR). Data were collected on days 0 and 90 and analyzed statistically, considering 5% significance. As for the anthropometric parameters, there was a difference between the groups only in terms of hip circumference, with a decrease in the TG and an increase in the CG. There was an increase in the glycemic level in the TG and a decrease in the CG. In the other biochemical parameters, the TG showed a greater reduction in all evaluated parameters, when compared to the CG, but without significant difference. The improvement in PD parameters (mainly in moderate pockets), CAL and RG were greater in the TG, but without statistical difference. The effectiveness of the probiotic as an adjunct in the non-surgical treatment of PD in type 2 diabetic patients cannot be verified in this study and does not support the hypothesis of improve to control glycemia and lipidemia.